These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11147681)

  • 21. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
    Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
    Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiostatin upregulates E-selectin in proliferating endothelial cells.
    Luo J; Lin J; Paranya G; Bischoff J
    Biochem Biophys Res Commun; 1998 Apr; 245(3):906-11. PubMed ID: 9588213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
    Stoeltzing O; Liu W; Reinmuth N; Parikh A; Ahmad SA; Jung YD; Fan F; Ellis LM
    Ann Surg Oncol; 2003 Aug; 10(7):722-33. PubMed ID: 12900362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
    Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
    Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potentials of angiostatin in the treatment of cancer.
    Cao Y
    Haematologica; 1999 Jul; 84(7):643-50. PubMed ID: 10406908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer.
    Wilczyńska U; Kucharska A; Szary J; Szala S
    Acta Biochim Pol; 2001; 48(4):1077-84. PubMed ID: 11995969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
    Pozzi A; LeVine WF; Gardner HA
    Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiostatin induces mitotic cell death of proliferating endothelial cells.
    Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
    Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Despite its homology to angiostatin apolipoprotein(a) does not affect angiogenesis.
    Lou XJ; Kwan HH; Prionas SD; Yang ZJ; Lawn RM; Fajardo LF
    Exp Mol Pathol; 1998 Oct; 65(2):53-63. PubMed ID: 9828147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL; Stack MS; Wahl ML; Pizzo SV
    Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 36. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.
    Benelli R; Morini M; Carrozzino F; Ferrari N; Minghelli S; Santi L; Cassatella M; Noonan DM; Albini A
    FASEB J; 2002 Feb; 16(2):267-9. PubMed ID: 11772950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis as a target for cancer therapy.
    Kaban K; Herbst RS
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1125-71. PubMed ID: 12512387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of multiple angiogenesis inhibitors by human pancreatic cancer.
    Kisker O; Onizuka S; Banyard J; Komiyama T; Becker CM; Achilles EG; Barnes CM; O'Reilly MS; Folkman J; Pirie-Shepherd SR
    Cancer Res; 2001 Oct; 61(19):7298-304. PubMed ID: 11585769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH.
    Wahl ML; Grant DS
    Gen Pharmacol; 2000 Nov; 35(5):277-85. PubMed ID: 11888684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.